The Altman Clinical and Translational Research Institute at University of California San Diego has received a five-year, $54.7 million Clinical and Translational Science Award from the National Center for Advancing Translational Science (NCATS), part of the National Institutes of Health.
Federal funding will fuel new innovations combining basic science and clinical care; brings total support to $140 million since institute opened in 2010
UC San Diego scientists have launched a clinical trial to investigate whether a drug approved for treating high blood pressure might also reduce the severity of COVID-19 infections, lowering rates for intensive care unit admissions, the use of mechanical ventilators and all-cause mortality.
ACE inhibitor drugs like Ramipril are widely used for various cardiovascular conditions; researchers want to see if they might also provide benefit to patients infected by SARS-CoV-2
UC San Diego Health has launched a Phase III clinical trial to assess whether a medication used to treat rheumatoid might also have therapeutic value for patient with COVID-19 who have developed or are at high risk of developing serious lung damage from SARS-CoV-2 infections.
Health Media Contacts
Find the best contact for health-related media inquiries.
